MAZE - Company ID 0001842295
The table below shows Maze Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Cash & equivalents | $198.77M | $316.77M | $264.54M | $294.37M |
| Short-term investments | $153.62M | $67.16M | - | - |
| Receivables | $20.00M | - | - | - |
| Inventory | - | - | - | - |
| Total current assets | $379.78M | $391.30M | $271.15M | $299.71M |
| Property, plant & equipment | $4.68M | $5.54M | $6.01M | $6.31M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Goodwill | - | - | - | - |
| Total assets | $419.71M | $422.06M | $303.52M | $332.84M |
| Accounts payable | $4.01M | $2.92M | $3.67M | $2.40M |
| Total current liabilities | $21.24M | $22.11M | $19.90M | $18.62M |
| Long-term debt | $38.83M | - | - | - |
| Total liabilities | $78.01M | $42.62M | $41.28M | $40.77M |
| Retained earnings | -$513.75M | -$454.98M | -$424.89M | -$391.21M |
| Total equity | $341.70M | $379.44M | $262.24M | $292.07M |